{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:41:25Z","timestamp":1790188885495,"version":"4.1.0"},"reference-count":56,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2018,1,6]],"date-time":"2018-01-06T00:00:00Z","timestamp":1515196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Histone deacetylation, together with altered acetylation of NF-\u03baB\/RelA, encompassing the K310 residue acetylation, occur during brain ischemia. By restoring the normal acetylation condition, we previously reported that sub-threshold doses of resveratrol and entinostat (MS-275), respectively, an activator of the AMP-activated kinase (AMPK)-sirtuin 1 pathway and an inhibitor of class I histone deacetylases (HDACs), synergistically elicited neuroprotection in a mouse model of ischemic stroke. To improve the translational power of this approach, we investigated the efficacy of MS-275 replacement with valproate, the antiepileptic drug also reported to be a class I HDAC blocker. In cortical neurons previously exposed to oxygen glucose deprivation (OGD), valproate elicited neuroprotection at 100 nmol\/mL concentration when used alone and at 1 nmol\/mL concentration when associated with resveratrol (3 nmol\/mL). Resveratrol and valproate restored the acetylation of histone H3 (K9\/18), and they reduced the RelA(K310) acetylation and the Bim level in neurons exposed to OGD. Chromatin immunoprecipitation analysis showed that the synergistic drug association impaired the RelA binding to the Bim promoter, as well as the promoter-specific H3 (K9\/18) acetylation. In mice subjected to 60 min of middle cerebral artery occlusion (MCAO), the association of resveratrol 680 \u00b5g\/kg and valproate 200 \u00b5g\/kg significantly reduced the infarct volume as well as the neurological deficits. The present study suggests that valproate and resveratrol may represent a promising ready-to-use strategy to treat post-ischemic brain damage.<\/jats:p>","DOI":"10.3390\/ijms19010172","type":"journal-article","created":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T12:26:02Z","timestamp":1515414362000},"page":"172","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Synergistic Association of Valproate and Resveratrol Reduces Brain Injury in Ischemic Stroke"],"prefix":"10.3390","volume":"19","author":[{"given":"Lara","family":"Faggi","sequence":"first","affiliation":[{"name":"Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7290-4397","authenticated-orcid":false,"given":"Giuseppe","family":"Pignataro","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Reproductive Sciences and Dentistry, University of Naples Federico II, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0365-5144","authenticated-orcid":false,"given":"Edoardo","family":"Parrella","sequence":"additional","affiliation":[{"name":"Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8222-155X","authenticated-orcid":false,"given":"Vanessa","family":"Porrini","sequence":"additional","affiliation":[{"name":"Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Vinciguerra","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Reproductive Sciences and Dentistry, University of Naples Federico II, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Cepparulo","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Reproductive Sciences and Dentistry, University of Naples Federico II, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ornella","family":"Cuomo","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Reproductive Sciences and Dentistry, University of Naples Federico II, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Lanzillotta","sequence":"additional","affiliation":[{"name":"Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Mota","sequence":"additional","affiliation":[{"name":"Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Benarese","sequence":"additional","affiliation":[{"name":"Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Tonin","sequence":"additional","affiliation":[{"name":"IRCCS, S. Camillo Hospital, 30126 Venice, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio","family":"Annunziato","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Reproductive Sciences and Dentistry, University of Naples Federico II, 80131 Naples, Italy"},{"name":"IRCCS, SDN, Via Gianturco, 113, 80142 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PierFranco","family":"Spano","sequence":"additional","affiliation":[{"name":"Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy"},{"name":"IRCCS, S. Camillo Hospital, 30126 Venice, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4857-5204","authenticated-orcid":false,"given":"Marina","family":"Pizzi","sequence":"additional","affiliation":[{"name":"Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy"},{"name":"IRCCS, S. Camillo Hospital, 30126 Venice, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,1,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/ana.23993","article-title":"Advances and challenges in treatment and prevention of ischemic stroke","volume":"74","author":"Grossman","year":"2013","journal-title":"Ann. Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1602\/neurorx.1.1.36","article-title":"Neuroprotection for ischemic stroke: Two decades of success and failure","volume":"1","author":"Cheng","year":"2004","journal-title":"NeuroRx"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e813","DOI":"10.1097\/MD.0000000000000813","article-title":"Peripheral frequency of cd4+ cd28\u2212 cells in acute ischemic stroke: Relationship with stroke subtype and severity markers","volume":"94","author":"Tuttolomondo","year":"2015","journal-title":"Medicine"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.neuint.2011.11.009","article-title":"Reactive oxygen species and ischemic cerebrovascular disease","volume":"60","author":"Olmez","year":"2012","journal-title":"Neurochem. Int."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s12035-007-8013-9","article-title":"Molecular mechanisms of apoptosis in cerebral ischemia: Multiple neuroprotective opportunities","volume":"37","author":"Nakka","year":"2008","journal-title":"Mol. Neurobiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1747-4949.2009.00387.x","article-title":"Oxidative stress and its role in the pathogenesis of ischaemic stroke","volume":"4","author":"Allen","year":"2009","journal-title":"Int. J. Stroke"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"12896","DOI":"10.1523\/JNEUROSCI.3670-06.2006","article-title":"Bim and noxa are candidates to mediate the deleterious effect of the NF-\u03baB subunit rela in cerebral ischemia","volume":"26","author":"Inta","year":"2006","journal-title":"J. Neurosci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1038\/cddis.2010.76","article-title":"The acetylation of rela in lys310 dictates the NF-\u03baB-dependent response in post-ischemic injury","volume":"1","author":"Lanzillotta","year":"2010","journal-title":"Cell. Death Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.nbd.2012.08.018","article-title":"Targeted acetylation of NF-\u03baB\/rela and histones by epigenetic drugs reduces post-ischemic brain injury in mice with an extended therapeutic window","volume":"49","author":"Lanzillotta","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.biopsych.2008.09.002","article-title":"Experience-dependent epigenetic modifications in the central nervous system","volume":"65","author":"Sweatt","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1385\/JMN:16:1:49","article-title":"Cyclic amp response element binding protein (CREB) and CREB binding protein (Cbp) in global cerebral ischemia","volume":"16","author":"Jin","year":"2001","journal-title":"J. Mol. Neurosci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1093\/emboj\/cdg615","article-title":"Critical loss of CBP\/p300 histone acetylase activity by caspase-6 during neurodegeneration","volume":"22","author":"Rouaux","year":"2003","journal-title":"EMBO J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1124\/mol.106.027912","article-title":"Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain","volume":"70","author":"Faraco","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1124\/jpet.107.120188","article-title":"Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: Multiple mechanisms of action","volume":"321","author":"Kim","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/j.1471-4159.2009.06212.x","article-title":"The HDAC inhibitor, sodium butyrate, stimulates neurogenesis in the ischemic brain","volume":"110","author":"Kim","year":"2009","journal-title":"J. Neurochem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1523\/JNEUROSCI.3200-07.2008","article-title":"Pulse inhibition of histone deacetylases induces complete resistance to oxidative death in cortical neurons without toxicity and reveals a role for cytoplasmic p21(waf1\/cip1) in cell cycle-independent neuroprotection","volume":"28","author":"Langley","year":"2008","journal-title":"J. Neurosci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"448","DOI":"10.2119\/molmed.2011.00038","article-title":"Histone deacetylase inhibitors as therapeutic agents for acute central nervous system injuries","volume":"17","author":"Shein","year":"2011","journal-title":"Mol. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"6712","DOI":"10.1523\/JNEUROSCI.0341-17.2017","article-title":"Opening a new time window for treatment of stroke by targeting HDAC2","volume":"37","author":"Lin","year":"2017","journal-title":"J. Neurosci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrg2485","article-title":"The many roles of histone deacetylases in development and physiology: Implications for disease and therapy","volume":"10","author":"Haberland","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.biocel.2013.05.037","article-title":"NF-\u03baB: Emerging roles in hippocampal development and function","volume":"45","author":"Crampton","year":"2013","journal-title":"Int J. Biochem. Cell. Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejphar.2006.06.027","article-title":"Distinct roles of diverse nuclear factor-kappab complexes in neuropathological mechanisms","volume":"545","author":"Pizzi","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1517\/14728222.11.2.123","article-title":"NF-\u03baB as a therapeutic target in neurodegenerative diseases","volume":"11","author":"Camandola","year":"2007","journal-title":"Expert. Opin. Ther. Targets"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fneur.2015.00098","article-title":"NF-\u03baB in innate neuroprotection and age-related neurodegenerative diseases","volume":"6","author":"Lanzillotta","year":"2015","journal-title":"Front. Neurol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Ingrassia, R., Lanzillotta, A., Sarnico, I., Benarese, M., Blasi, F., Borgese, L., Bilo, F., Depero, L., Chiarugi, A., and Spano, P.F. (2012). 1b\/(\u2212)ire dmt1 expression during brain ischemia contributes to cell death mediated by NF-\u03baB\/rela acetylation at lys310. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0038019"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/0470862637.ch15","article-title":"Regulation of NF-kappaB action by reversible acetylation","volume":"259","author":"Greene","year":"2004","journal-title":"Novartis Found. Symp."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1038\/sj.emboj.7600244","article-title":"Modulation of NF-kappaB-dependent transcription and cell survival by the sirt1 deacetylase","volume":"23","author":"Yeung","year":"2004","journal-title":"EMBO J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1073\/pnas.0510341103","article-title":"The benzamide ms-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylases","volume":"103","author":"Simonini","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/jcbfm.2010.229","article-title":"Pathways for ischemic cytoprotection: Role of sirtuins in caloric restriction, resveratrol, and ischemic preconditioning","volume":"31","author":"Morris","year":"2011","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1007\/s11064-011-0561-8","article-title":"Resveratrol pretreatment attenuates cerebral ischemic injury by upregulating expression of transcription factor Nrf2 and Ho-1 in rats","volume":"36","author":"Ren","year":"2011","journal-title":"Neurochem. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1096\/fj.04-3425fje","article-title":"Association of valproate-induced teratogenesis with histone deacetylase inhibition in vivo","volume":"19","author":"Gurvich","year":"2005","journal-title":"FASEB J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1042\/BJ20070779","article-title":"Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors","volume":"409","author":"Khan","year":"2008","journal-title":"Biochem. J."},{"key":"ref_32","first-page":"316","article-title":"Post-insult valproic acid-regulated micrornas: Potential targets for cerebral ischemia","volume":"4","author":"Hunsberger","year":"2012","journal-title":"Am. J. Transl. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1161\/STROKEAHA.112.652545","article-title":"Chronic valproate treatment enhances postischemic angiogenesis and promotes functional recovery in a rat model of ischemic stroke","volume":"43","author":"Wang","year":"2012","journal-title":"Stroke"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/j.1471-4159.2004.02406.x","article-title":"Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: Potential roles of histone deacetylase inhibition and heat shock protein induction","volume":"89","author":"Ren","year":"2004","journal-title":"J. Neurochem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/01.STR.0000217303.22856.38","article-title":"Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia","volume":"37","author":"Costa","year":"2006","journal-title":"Stroke"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.eplepsyres.2011.04.002","article-title":"Are post intracerebral hemorrhage seizures prevented by anti-epileptic treatment?","volume":"95","author":"Gilad","year":"2011","journal-title":"Epilepsy Res."},{"key":"ref_37","first-page":"820","article-title":"Post-insult valproate treatment potentially improved functional recovery in patients with acute middle cerebral artery infarction","volume":"6","author":"Lee","year":"2014","journal-title":"Am. J. Transl. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1080\/01616412.1997.11740874","article-title":"Monofilament intraluminal middle cerebral artery occlusion in the mouse","volume":"19","author":"Clark","year":"1997","journal-title":"Neurol. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1161\/01.STR.29.10.2136","article-title":"Citicoline treatment for experimental intracerebral hemorrhage in mice","volume":"29","author":"Clark","year":"1998","journal-title":"Stroke"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00023210-200216100-00003","article-title":"Basic pharmacology of valproate: A review after 35 years of clinical use for the treatment of epilepsy","volume":"16","year":"2002","journal-title":"CNS Drugs"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1046\/j.1471-4159.2003.01581.x","article-title":"Selective e2f-dependent gene transcription is controlled by histone deacetylase activity during neuronal apoptosis","volume":"84","author":"Boutillier","year":"2003","journal-title":"J. Neurochem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bbrc.2005.11.151","article-title":"Dual effects of histone deacetylase inhibition by trichostatin a on endothelial nitric oxide synthase expression in endothelial cells","volume":"340","author":"Gan","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/nar\/28.8.1707","article-title":". Transcriptional repression by the insulator protein ctcf involves histone deacetylases","volume":"28","author":"Lutz","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Yildirim, F., Ji, S., Kronenberg, G., Barco, A., Olivares, R., Benito, E., Dirnagl, U., Gertz, K., Endres, M., and Harms, C. (2014). Histone acetylation and creb binding protein are required for neuronal resistance against ischemic injury. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0095465"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.lfs.2012.01.001","article-title":"Neuroprotective effects of valproic acid following transient global ischemia in rats","volume":"90","author":"Xuan","year":"2012","journal-title":"Life Sci."},{"key":"ref_46","first-page":"1","article-title":"Attenuation by acetyl-l-carnitine of neurological damage and biochemical derangement following brain ischemia and reperfusion","volume":"21","author":"Calvani","year":"1999","journal-title":"Int. J. Tissue React."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/jnr.20293","article-title":"Pyruvate dehydrogenase complex: Metabolic link to ischemic brain injury and target of oxidative stress","volume":"79","author":"Martin","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1046\/j.1471-4159.1999.721707.x","article-title":"Cellular distribution and developmental expression of amp-activated protein kinase isoforms in mouse central nervous system","volume":"72","author":"Turnley","year":"1999","journal-title":"J. Neurochem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"E751","DOI":"10.1152\/ajpendo.00745.2009","article-title":"Ampk and sirt1: A long-standing partnership?","volume":"298","author":"Ruderman","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1471-4159.2008.05783.x","article-title":"NF-kappaB p50\/rela and c-rel-containing dimers: Opposite regulators of neuron vulnerability to ischaemia","volume":"108","author":"Sarnico","year":"2009","journal-title":"J. Neurochem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1523\/JNEUROSCI.4912-07.2008","article-title":"A critical role for the potassium-dependent sodium-calcium exchanger nckx2 in protection against focal ischemic brain damage","volume":"28","author":"Cuomo","year":"2008","journal-title":"J. Neurosci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1523\/JNEUROSCI.4671-07.2008","article-title":"Targeted disruption of Na+\/Ca2+ exchanger 3 (ncx3) gene leads to a worsening of ischemic brain damage","volume":"28","author":"Molinaro","year":"2008","journal-title":"J. Neurosci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1161\/STROKEAHA.107.488486","article-title":"Antithrombin reduces ischemic volume, ameliorates neurologic deficits, and prolongs animal survival in both transient and permanent focal ischemia","volume":"38","author":"Cuomo","year":"2007","journal-title":"Stroke"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3171\/jns.1986.64.5.0795","article-title":"Nuclear magnetic resonance imaging and spectroscopy in experimental brain edema in a rat model","volume":"64","author":"Bederson","year":"1986","journal-title":"J. Neurosurg."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/sj.jcbfm.9600559","article-title":"In vivo and in vitro characterization of a novel neuroprotective strategy for stroke: Ischemic postconditioning","volume":"28","author":"Pignataro","year":"2008","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0891-5849(02)00911-5","article-title":"Inhibition of cancer growth by resveratrol is related to its low bioavailability","volume":"33","author":"Asensi","year":"2002","journal-title":"Free Radic. Biol. Med."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/1\/172\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T14:50:22Z","timestamp":1760194222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/1\/172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,6]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1]]}},"alternative-id":["ijms19010172"],"URL":"https:\/\/doi.org\/10.3390\/ijms19010172","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,6]]}}}